FDA to Issue New Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests
For Immediate Release:June 17, 2025 The U.S. Food and Drug Administration today announced its Commissioner’s National Priority Voucher (CNPV) program to enhance the health interests of Americans. The new voucher may be redeemed by drug developers to participate in a novel priority program by the FDA that shortens its review